Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


04.06.2018

20 AIDS
2 AIDS Res Hum Retroviruses
1 Ann Intern Med
1 Antimicrob Agents Chemother
1 Br J Haematol
1 Clin Infect Dis
2 HIV Med
10 J Acquir Immune Defic Syndr
5 J Infect Dis
3 J Med Virol
4 J Virol
3 JAMA
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
4 Pediatr Infect Dis J
16 PLoS One
1 PLoS Pathog
1 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. ATTIA EF, Maleche-Obimbo E, West TE, Ndukwe-Wambutsi L, et al
    Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.
    AIDS. 2018;32:1353-1359.
    PubMed     Text format     Abstract available

  2. LE ROUX S, Donald K, Brittain K, Phillips TK, et al
    Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa: a prospective cohort.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001872.
    PubMed     Text format     Abstract available

  3. GLESBY MJ, Hanna DB, Hoover DR, Shi Q, et al
    Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001873.
    PubMed     Text format     Abstract available

  4. WU M, Fatukasi O, Yang S, Alger J, et al
    HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001891.
    PubMed     Text format     Abstract available

  5. BARTLETT AW, Khanh TH, Songtaweesin WN, Chokephaibulkit K, et al
    Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001883.
    PubMed     Text format     Abstract available

  6. KOUYOUMJIAN SP, Heijnen M, Chaabna K, Mumtaz GR, et al
    Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.
    AIDS. 2018;32:1343-1352.
    PubMed     Text format     Abstract available

  7. HAWKINS KL, Zhang L, Ng DK, Althoff KN, et al
    Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.
    AIDS. 2018;32:1257-1266.
    PubMed     Text format     Abstract available

  8. JOHNSON WD, O'Leary A, Flores SA
    Per-partner condom effectiveness for men who have receptive sex with HIV-positive men.
    AIDS. 2018 May 1. doi: 10.1097/QAD.0000000000001832.
    PubMed     Text format     Abstract available

  9. ZHANG Y, Fogel JM, Guo X, Clarke W, et al
    Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.
    AIDS. 2018;32:1301-1306.
    PubMed     Text format     Abstract available

  10. SIEDNER MJ, Hettema A, Hughey A, Oldenburg CE, et al
    Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001859.
    PubMed     Text format     Abstract available

  11. KOLBER MA
    HIV solid organ transplantation: looking beyond HOPE.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001892.
    PubMed     Text format    

  12. JAFFE HW
    Lessons from the early HIV/AIDS epidemic.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001877.
    PubMed     Text format    

  13. AHMAD A, Mehraj V, Jenabian MA, Routy JP, et al
    Anti-Gag antibodies gag HIV infection and slow disease progression.
    AIDS. 2018;32:1373-1375.
    PubMed     Text format    

  14. ROBBINS HA
    Lung cancer screening in people living with HIV: modeling to bridge the evidence.
    AIDS. 2018;32:1369-1371.
    PubMed     Text format    

  15. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio.
    AIDS. 2018;32:1361-1367.
    PubMed     Text format     Abstract available

  16. PRESTI RM, Handley SA, Droit L, Ghannoum M, et al
    Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.
    AIDS. 2018;32:1279-1287.
    PubMed     Text format     Abstract available

  17. SHAPIRO AE, Hong T, Govere S, Thulare H, et al
    C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001902.
    PubMed     Text format     Abstract available

  18. WOOLNOUGH EL, Hoy JF, Cheng AC, Walker RG, et al
    Predictors of chronic kidney disease and utility of risk prediction scores in HIV positive individuals.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001901.
    PubMed     Text format     Abstract available

  19. RONIT A, Hatleberg CI, Ryom L, Bonnet F, et al
    Associations between serum albumin and serious non-AIDS events among people living with HIV.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900.
    PubMed     Text format     Abstract available

  20. MILLS EJ, Adhvaryu A, Jakiela P, Birungi J, et al
    Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households: a bayesian randomised trial.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001899.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  21. LEWY T, Hong BY, Weiser B, Burger H, et al
    Oral microbiome in HIV-infected women: Shifts in the abundance of pathogenic and beneficial bacteria are associated with aging, HIV load, CD4 count, and ART.
    AIDS Res Hum Retroviruses. 2018 May 29. doi: 10.1089/AID.2017.0200.
    PubMed     Text format     Abstract available

  22. ARIZALA JA, Takahashi M, Burnett JC, Ouellet DL, et al
    Nucleolar Localization of HIV-1 Rev is Required Yet Insufficient for Production of Infectious Viral Particles.
    AIDS Res Hum Retroviruses. 2018 May 26. doi: 10.1089/AID.2017.0306.
    PubMed     Text format     Abstract available


    Ann Intern Med

  23. SHIELS MS, Islam JY, Rosenberg PS, Hall HI, et al
    Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Ann Intern Med. 2018 May 8. pii: 2680725. doi: 10.7326/M17-2499.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  24. SPADARI CC, Vila T, Rozental S, Ishida K, et al
    Miltefosine has post-antifungal effect and induces apoptosis in Cryptococcus yeasts.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00312.
    PubMed     Text format     Abstract available


    Br J Haematol

  25. FAMA A, Xiang J, Link BK, Allmer C, et al
    Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
    Br J Haematol. 2018 May 29. doi: 10.1111/bjh.15416.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  26. RHEE SY, Clutter D, Fessel WJ, Klein D, et al
    Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance in a Large U.S. Clinic Population.
    Clin Infect Dis. 2018 May 26. pii: 5005024. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  27. TARAMASSO L, Di Biagio A, Maggiolo F, Tavelli A, et al
    First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.
    HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.
    PubMed     Text format     Abstract available

  28. HENTZIEN M, Cabie A, Pugliese P, Billaud E, et al
    Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
    HIV Med. 2018 Jun 1. doi: 10.1111/hiv.12633.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  29. MAKI PM, Rubin LH, Springer G, Seaberg EC, et al
    Differences in Cognitive Function between Women and Men with HIV.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001764.
    PubMed     Text format     Abstract available

  30. SALESKA JL, Turner AN, Maierhofer C, Clark J, et al
    Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in low and middle-income countries: a systematic review.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001770.
    PubMed     Text format     Abstract available

  31. PORTER K, Gourlay A, Attawell K, Hales D, et al
    Substantial heterogeneity in progress towards reaching the 90-90-90 HIV target in the WHO European Region.
    J Acquir Immune Defic Syndr. 2018 May 25. doi: 10.1097/QAI.0000000000001761.
    PubMed     Text format     Abstract available

  32. KOETHE JR, Jenkins CA, Furch BD, Lake JE, et al
    Circulating Markers of Immunologic Activity Reflect Adiposity in Persons with HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 May 23. doi: 10.1097/QAI.0000000000001768.
    PubMed     Text format     Abstract available

  33. CHEN S, Wang X, Zhu H, Tang Q, et al
    Zidovudine-based treatments inhibit the glycosylation of ADAM17 and reduce CD163 shedding from monocytes.
    J Acquir Immune Defic Syndr. 2018 May 23. doi: 10.1097/QAI.0000000000001769.
    PubMed     Text format     Abstract available

  34. ALPEREN J, Davidson J, Siminski S, Seage GR 3rd, et al
    The Utility of the National Death Index in Identifying Deaths in a Clinic-based, Multi-site Cohort: The Experience of the Pediatric HIV/AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001763.
    PubMed     Text format    

  35. ORTBLAD KF, Musoke DK, Ngabirano T, Nakitende A, et al
    Female sex workers often incorrectly interpret HIV self-test results in Uganda.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001765.
    PubMed     Text format    

  36. STONER MC, Edwards JK, Miller WC, Aiello AE, et al
    Does partner selection mediate the relationship between school attendance and HIV/HSV-2 among adolescent girls and young women in South Africa: An analysis of HPTN 068 data.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001766.
    PubMed     Text format     Abstract available

  37. CALABRESE SK, Dovidio JF, Tekeste M, Taggart T, et al
    HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001762.
    PubMed     Text format     Abstract available

  38. GOGIA S, Coromilas A, Regan S, Stone L, et al
    Cardiovascular Risk Profile of Transgender Women with HIV: A U.S. Healthcare Database Study.
    J Acquir Immune Defic Syndr. 2018 May 22. doi: 10.1097/QAI.0000000000001767.
    PubMed     Text format     Abstract available


    J Infect Dis


  39. Erratum to Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
    J Infect Dis. 2018 May 24. pii: 5003198. doi: 10.1093.
    PubMed     Text format    

  40. ANDERSEN MN, Honge BL, Jespersen S, Medina C, et al
    Soluble Macrophage Mannose Receptor (sCD206/sMR) as a Biomarker in HIV-infection.
    J Infect Dis. 2018 May 25. pii: 5003428. doi: 10.1093.
    PubMed     Text format     Abstract available

  41. PERCIANI CT, Sekhon M, Hundal S, Farah B, et al
    Live-attenuated Zoster Vaccine Boosts VZV-specific Humoral Responses Systemically and at the Cervico-vaginal Mucosa of Kenyan VZV-seropositive Women.
    J Infect Dis. 2018 May 25. pii: 5003463. doi: 10.1093.
    PubMed     Text format     Abstract available

  42. VON MOLLENDORF C, Hellferscee O, Valley-Omar Z, Treurnicht FK, et al
    Influenza viral shedding in a prospective cohort of HIV-infected and -uninfected children and adults in 2 provinces of South Africa, 2012-2014.
    J Infect Dis. 2018 May 24. pii: 5002738. doi: 10.1093.
    PubMed     Text format     Abstract available

  43. KELLY H, Faust H, Chikandiwa A, Ngou J, et al
    Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    J Infect Dis. 2018 May 30. pii: 5025554. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  44. SMELOV V, Elfstrom KM, Eklund C, Sokolova O, et al
    Determinants of presence of human papillomaviruses in the anal canal of Russian men.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25234.
    PubMed     Text format     Abstract available

  45. TAMALET C, Tissot-Dupont H, Motte A, Tourres C, et al
    Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25228.
    PubMed     Text format     Abstract available

  46. HILDENBRAND C, Wedekind L, Li G, vonRentzell JE, et al
    Clinical evaluation of Roche COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) CMV Test using non-plasma samples.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25226.
    PubMed     Text format     Abstract available


    J Virol

  47. BAIYEGUNHI O, Ndlovu B, Ogunshola F, Ismail N, et al
    Frequencies of circulating Th1-biased T follicular helper cells in acute HIV-1 infection correlate with the development of HIV-specific antibody responses and lower set point viral load.
    J Virol. 2018 May 23. pii: JVI.00659-18. doi: 10.1128/JVI.00659.
    PubMed     Text format     Abstract available

  48. ANTONUCCI JM, Kim SH, St Gelais C, Bonifati S, et al
    SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4(+) T-cells.
    J Virol. 2018 May 23. pii: JVI.00292-18. doi: 10.1128/JVI.00292.
    PubMed     Text format     Abstract available

  49. SINGH S, Ramirez-Salazar EG, Doueiri R, Valentin A, et al
    Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques.
    J Virol. 2018 May 23. pii: JVI.00281-18. doi: 10.1128/JVI.00281.
    PubMed     Text format     Abstract available

  50. KANG ZH, Bricault CA, Borducchi EN, Stephenson KE, et al
    Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys.
    J Virol. 2018 May 23. pii: JVI.00537-18. doi: 10.1128/JVI.00537.
    PubMed     Text format     Abstract available


    JAMA

  51. RUBIN R
    A Day in the Life: Physician Cares for HIV-Positive Patients in Jail.
    JAMA. 2018 May 30. pii: 2683542. doi: 10.1001/jama.2018.5315.
    PubMed     Text format    

  52. SLOMSKI A
    Peer Counselors for Formerly Incarcerated People With HIV.
    JAMA. 2018;319:2069.
    PubMed     Text format    

  53. RUDD KE, Seymour CW, Aluisio AR, Augustin ME, et al
    Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries.
    JAMA. 2018 May 20. pii: 2681801. doi: 10.1001/jama.2018.6229.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  54. ZAID M, Afzal MS
    HIV outbreak in Pakistan.
    Lancet Infect Dis. 2018;18:601.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  55. BLAYLOCK JM, Hakre S, Okulicz JF, Garges E, et al
    HIV Preexposure Prophylaxis in the U.S. Military Services - 2014-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:569-574.
    PubMed     Text format     Abstract available


    N Engl J Med


  56. HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-2145.
    PubMed     Text format    

  57. ZUCMAN D, Mellot F, Couderc L
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-5.
    PubMed     Text format    

  58. CHAMSEDDINE AN, Loulergue P, Mir O
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144.
    PubMed     Text format    


    Pediatr Infect Dis J

  59. BUCK WC, Manjate N, Ventura J, Nhassengo C, et al
    Spinal Tuberculosis in Young Human Immunodeficiency Virus-Exposed Infants: Two Cases of Probable Congenital Transmission.
    Pediatr Infect Dis J. 2018 May 14. doi: 10.1097/INF.0000000000002118.
    PubMed     Text format     Abstract available

  60. INAGAKI K, Blackshear C, Hobbs CV
    Pneumocystis Infection in Children: National Trends and Characteristics in the United States, 1997-2012.
    Pediatr Infect Dis J. 2018 May 21. doi: 10.1097/INF.0000000000002119.
    PubMed     Text format     Abstract available

  61. NSANZIMANA S, McArdle F, Remera E, Mulindabigwi A, et al
    Viral Suppression in a Nationwide Sample of HIV-infected Children on Antiretroviral Therapy in Rwanda.
    Pediatr Infect Dis J. 2018 May 21. doi: 10.1097/INF.0000000000002101.
    PubMed     Text format     Abstract available

  62. AURPIBUL L, Kariminia A, Vibol U, Fong MS, et al
    Seroprevalence of Hepatitis B among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
    Pediatr Infect Dis J. 2018 Jan 15. doi: 10.1097/INF.0000000000001901.
    PubMed     Text format     Abstract available


    PLoS One

  63. CORONA E, Wang L, Ko D, Patel CJ, et al
    Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility.
    PLoS One. 2018;13:e0196676.
    PubMed     Text format     Abstract available

  64. DEVKOTA P, Danzi MC, Wuchty S
    Beyond degree and betweenness centrality: Alternative topological measures to predict viral targets.
    PLoS One. 2018;13:e0197595.
    PubMed     Text format     Abstract available

  65. NACHER M, Adriouch L, Huber F, Vantilcke V, et al
    Modeling of the HIV epidemic and continuum of care in French Guiana.
    PLoS One. 2018;13:e0197990.
    PubMed     Text format     Abstract available

  66. VALLEY-OMAR Z, Iyengar P, von Mollendorf C, Tempia S, et al
    Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa.
    PLoS One. 2018;13:e0198101.
    PubMed     Text format     Abstract available

  67. MBOUMBA BOUASSA RS, Mbeko Simaleko M, Camengo SP, Mossoro-Kpinde CD, et al
    Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.
    PLoS One. 2018;13:e0197845.
    PubMed     Text format     Abstract available

  68. TEASDALE CA, Abrams EJ, Chiasson MA, Justman J, et al
    Incidence of sexually transmitted infections during pregnancy.
    PLoS One. 2018;13:e0197696.
    PubMed     Text format     Abstract available

  69. SIMS EK, Park G, Mather KJ, Mirmira RG, et al
    Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function.
    PLoS One. 2018;13:e0197080.
    PubMed     Text format     Abstract available

  70. KULEAPE JA, Tagoe EA, Puplampu P, Bonney EY, et al
    Homozygous deletion of both GSTM1 and GSTT1 genes is associated with higher CD4+ T cell counts in Ghanaian HIV patients.
    PLoS One. 2018;13:e0195954.
    PubMed     Text format     Abstract available

  71. BLANCO RY, Loureiro CL, Villalba JA, Sulbaran YF, et al
    Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela.
    PLoS One. 2018;13:e0197662.
    PubMed     Text format     Abstract available

  72. ADEDIPE OE, Jacot TA, Thurman AR, Doncel GF, et al
    Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.
    PLoS One. 2018;13:e0197906.
    PubMed     Text format     Abstract available

  73. MUPFUMI L, Moyo S, Molebatsi K, Thami PK, et al
    Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.
    PLoS One. 2018;13:e0198711.
    PubMed     Text format     Abstract available

  74. PERRIER M, Desire N, Storto A, Todesco E, et al
    Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
    PLoS One. 2018;13:e0198334.
    PubMed     Text format     Abstract available

  75. KESTELYN E, Agaba S, Van Nuil JI, Uwineza M, et al
    A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.
    PLoS One. 2018;13:e0197572.
    PubMed     Text format     Abstract available

  76. ZIRABA A, Orindi B, Muuo S, Floyd S, et al
    Understanding HIV risks among adolescent girls and young women in informal settlements of Nairobi, Kenya: Lessons for DREAMS.
    PLoS One. 2018;13:e0197479.
    PubMed     Text format     Abstract available

  77. VAN BELLE S, Boydell V, George AS, Brinkerhof DW, et al
    Broadening understanding of accountability ecosystems in sexual and reproductive health and rights: A systematic review.
    PLoS One. 2018;13:e0196788.
    PubMed     Text format     Abstract available

  78. NEL A, Martins J, Bekker LG, Ramjee G, et al
    Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.
    PLoS One. 2018;13:e0196904.
    PubMed     Text format     Abstract available


    PLoS Pathog

  79. RAM DR, Manickam C, Hueber B, Itell HL, et al
    Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques.
    PLoS Pathog. 2018;14:e1007104.
    PubMed     Text format     Abstract available


    Vaccine

  80. DAMILANO GD, Sued O, Ruiz MJ, Ghiglione Y, et al
    Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection.
    Vaccine. 2018 May 22. pii: S0264-410X(18)30606.
    PubMed     Text format     Abstract available


    Virology

  81. MEFFERD AL, Bogerd HP, Irwan ID, Cullen BR, et al
    Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Virology. 2018;520:116-126.
    PubMed     Text format     Abstract available

  82. MARSDEN MD, Wu X, Navab SM, Loy BA, et al
    Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
    Virology. 2018;520:83-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: